Home » Life Science & Biotech

Life Science & Biotech

Articles

Startup drug firm lands veteran help: Immune Works, a fledgling firm with a promising lung drug, attracts former Indiana Health Industry Forum leader Lange

A startup firm using Indiana University medical research to treat a fatal lung disease is raising money for clinical trials and has recruited a prominent life sciences veteran to lead the effort. Michael Klemsz, an associate professor at the IU School of Medicine, and Dr. David Wilkes, director of the school’s Center for Immunobiology, founded Immune Works LLC in January 2006 along with Ronald Meeusen. Meeusen, a former Dow-AgroSciences researcher and BioCrossroads executive, served as a part-time president and CEO…

Read More

Indiana’s life sciences resources to be catalogued:

An idea fermenting for some time in the minds of several Indiana Health Industry Forum insiders has solidified into a plan to catalogue all life sciences-related resources across the state. The not-for-profit group, which promotes economic development in the health care and life sciences industries, will use the information to create strategies for communities, regions and the state to boost Indiana’s growth in the industry. Companies including Eli Lilly and Co., Roche Diagnostics and Zimmer Holdings have put the state…

Read More

VIEWPOINT: Domestic ‘insourcing’ our way to job growth

Anchor Lou Dobbs of CNN is a pest to some folks and a hero for others. His recurring economic message laments a view of U.S. workers losing out as companies send jobs overseas. Dobbs’ critics, of course, cite his convenient omission of the many interna tional companies that invest in U.S. communities through new manufacturing plants, research facilities and other initiatives. Love the debate or detest it, but consider this: Hasn’t Dobbs helped stir a discussion about how the new…

Read More

Speeding Toward Better Health: Regenstrief Institute continues to fine-tune a medical-records system that many think could someday become a national model

Regenstrief Institute continues to fine-tune a medical-records system that many think could someday become a national model The Regenstrief Institute is a racing team. Only instead of drivers and grease monkeys, the Indianapolis-based medical research group has doctors and computer geeks. And instead of a race car, Regenstrief runs a massive computer database with 35 years of medical records from Indianapolis-area patients. But Regenstrief’s mission is still all about speed. The not-for-profit is driving to discover better ways to care…

Read More

State beefs up incentives available to tech companies:

Companies receiving a Phase 1 SBIR match from the state need to apply for second-stage funding by July 20. Applications can be downloaded on the IEDC Web site. The proposal for funds should be no longer than 12 pages and include a commercialization plan describing how the product would be moved to market and any challenges that would need to be overcome. The proposal also should include a budget describing the funds required for The Indiana Economic Development Corp. has…

Read More

NOTIONS: Oh, the things we worry about in modern America

My wife, Cheri, and I live in one of those newfangled, don’tstray-from-the-mainstream neighborhoods. It’s governed by wellmeaning “covenants and restrictions.” It has “architectural control guidelines.” These documents were formulated by a “development control committee” to “enhance the value and appearance of the community.” (We’re especially concerned with the “value” part, until our property-tax bills arrive, at which point we protest the assessed value.) Included among the controls in our neighborhood is a color palette. I imagine some designer back in…

Read More

IU life sciences startup attracts former Lilly exec: INphoton attempts to commercialize high-tech cellular imaging techniques

It doesn’t have a headquarters or any full-time employees yet. But local life sciences startup INphoton LLC has attracted something equally important: an experienced manager. This month, INphoton hired Steven Plump, Eli Lilly and Co.’s former chief marketing officer, as its CEO. Plump, who retired from Lilly in 2006 after a 30-year career there, hopes to commercialize the high-tech research imaging techniques that INphoton’s founders discovered in Indiana University laboratories. In the process, INphoton could cut pharmaceutical companies’ cost of…

Read More

Agriculture goes urban: New academy plans to show city students that there’s more to horticulture than farming

Indiana’s stature as one of the nation’s top producers of corn and soybeans is as enduring as the fertile farmland in which the crops are grown. But a new initiative plans to introduce urban high school students in Indianapolis to a bushel of opportunities within the agriculture industry that extends well beyond farming. The Hoosier Agribusiness and Science Academy is a partnership between state government and Ivy Tech Community College in which students from the Lawrence Early College High School…

Read More

Orphan Lilly antibiotic spurs $86.3 million IPO plan: Targanta Therapeutics aims to commercialize drug

A biotech company that’s attempting to commercialize an antibiotic developed by Eli Lilly and Co. has filed for an $86.3 million initial public offering. Targanta Therapeutics Corp. two years ago bought the rights to Lilly’s skin infection treatment, oritavancin. The company briefly had its headquarters in Indianapolis before moving it to Cambridge, Mass., last year. Lilly will see a big payoff if Targanta succeeds. The company’s IPO filing says it must pay the Indianapolis pharma giant $10 million when oritavancin…

Read More

CHRIS KATTERJOHN Commentary: ‘Rip’ is just right for CICP

It’s been 15 months since Central Indiana Corporate Partnership CEO Mark Miles wrote in these pages that he felt like Rip Van Winkle when he returned to the city after being away for 15 years. Miles has done anything but sleep since he got back. Neither has the CICP board of directors. That group should be congratulated for making an outstanding choice of a new leader and for taking bold steps forward. This seems to have been a perfect match…

Read More

Techpoint honors Indiana companies, educators: Judges narrow 80 nominees to 13 Mira winners

This year’s recipients of Techpoint’s Mira awards include some of the area’s best-known technology startups as well as lower-profile firms that have racked up big achievements. On May 18, the technology trade group was scheduled to acknowledge the accomplishments of Hoosier entrepreneurs in information technology, life sciences, advanced manufacturing and education with its eighth annual gala at the Indiana Roof Ballroom downtown. “It’s always good to recognize companies and give them a pat on the back, put them on the…

Read More

Back from key conference, leaders focus on follow-up: Life science delegation faced big task: standing out among 20,000 attendees

The Indiana Economic Development Corp. spent the last six months preparing for the May 6-9 Biotechnology Industry Organization convention, the life sciences industry’s biggest annual event. Now that it’s finished, the hard part begins. “You build the relationship and you get the contacts,” said Indiana Secretary of Commerce Nathan Feltman. “But then you’ve got to aggressively follow up to get them here in Indiana.” More than 20,000 of the life sciences sector’s movers and shakers converged in Boston for the…

Read More

STATEHOUSE DISPATCH: Gambling quenched lawmakers’ appetite for new revenue

The 2007 session of the Indiana General Assembly is now history. Whatever else might have been involved in shaping its outcome, nothing was so determinative as the revelation in the closing days that property taxes-driven by the first application of trending, rising property values in general, the elimination of the inventory tax, and some old-fashioned political legerdemain on the part of some assessors in different regions of the state-were expected to rise an average of 24 percent for taxes payable…

Read More

Pension changes fill state’s VC coffer: Indiana Investment Fund has $155 million to pour into Hoosier companies

The diversification of the state’s two enormous public pension funds into private equity is transforming Indiana’s venture capital sector. And their $155 million Indiana Investment Fund is the largest factor in the equation. If it’s successful, the Indiana Public Employees’ Retirement Fund and the Indiana State Teachers’ Retirement Fund will save Hoosiers untold millions of dollars and help launch a host of new high-tech companies. If it’s not, taxpayers will one day have to foot the bill. Indiana State Budget…

Read More

Embarking on a new Venture: New leader planning progressive changes at center, not a total revamping

The new leader of the Indiana Venture Center is beginning to put his stamp on the not-for-profit that mentors promising startups. James Eifert, 64, is the former president of Terre Haute-based Rose-Hulman Ventures who took charge of the center in December following the July resignation of Steve Beck. Beck left to become co-managing director of IVC Equity Partners, a new local seed-capital fund. Chief items on Eifert’s to-do list are broadening the donor base, revamping the Venture Center’s proprietary network…

Read More

VOICES FROM THE INDUSTRY: Communications as usual just won’t cut it anymore

In 1999, when the World Wide Web was in its infancy, Rick Levine and others penned and posted “The Cluetrain Manifesto: The end of business as usual” (www.cluetrain.com). In this Web-focused document, their opening salvo at business as usual-and their wake-up call for American business- went thusly: “A powerful global conversation has begun. Through the Internet, people are discovering and inventing new ways to share relevant knowledge with blinding speed. As a direct result, markets are getting smarter-and getting smarter…

Read More

STATEHOUSE DISPATCH: Desperate for cash, lawmakers embrace gambling

We recently told you how revenue growth was lagging the December fiscal forecast. One prominent Republican senator tells his constituents that his colleagues are now planning for a growth rate in this fiscal year of only 2.5 percent, not the 4.2 percent to 4.5 percent they had planned on at the beginning of the session. While lawmakers will not have a new fiscal forecast for the biennium until the middle of April, they are clearly girding for a new fiscal…

Read More

MICKEY MAURER Commentary: The power of a single ‘thank you’

One of the most enjoyable aspects of my job as president of the Indiana Economic Development Corp. and secretary of commerce was the opportunity to represent our governor and the state of Indiana on goodnews occasions. On April 26, 2005, I bestowed official state certification on Intech Park, a business incubator that had qualified under the Indiana Certified Technology Park Program. Certified tech parks enjoy the advantage of being allowed to capture and invest in the development of their park…

Read More

Oxford BioSignals poised to add up to 120 jobs: Indiana’s life sciences market, $2.7 million in incentives attract medical startup

How does aviation technology conceived at Oxford University and developed with the help of Rolls-Royce end up being tested at Methodist Hospital and commercialized in Carmel? Oxford BioSignals Medical CEO Frank Cheng knows the answer. Even better, he can explain why his startup is poised to add 120 jobs over the next few years. “At this point, I don’t see anything we can’t do right here in Indiana,” he said. Formed in 2000, Oxford BioSignals began its life when research…

Read More